MAR 14, 2019 9:00 AM PDT

A Gene Expression Based Screening Platform for Mouse Models of Late-Onset Alzheimer's Disease

Presented at: Neuroscience 2019
Sponsored by: NanoString Technologies
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor, The Jackson Laboratory
    Biography
      Greg Carter's laboratory combines genetic, genomic, imaging, and other data resources to understand the causes and progression of Alzheimer's disease. Greg is also the director of the Bioinformatics and Data Management Core of the IU/JAX Model Organism Development and Evaluation for Late-onset Alzheimer's Disease (MODEL-AD) Center. As a lead investigator for MODEL-AD, he is primarily focused on creating new animal models that better replicate human Alzheimer's disease and related-dementias. These models are being used to dissect the genetics, genomics, and neuropathology of late-onset Alzheimer's, and provide vital models for preclinical testing of candidate therapeutics.

    Abstract

    Late-onset Alzheimer’s disease (LOAD) is the most common form of dementia worldwide. To date, animal models of Alzheimer’s have focused on rare familial mutations, due to a lack of frank neuropathology from models based on common disease genes. Recent multi-cohort studies of postmortem human brain transcriptomes have identified a set of 30 gene co-expression modules associated with LOAD, providing a molecular catalog of relevant endophenotypes. This resource enables precise gene-based alignment between new animal models and human molecular signatures of disease. Here, we describe a new resource to efficiently screen mouse models for LOAD relevance. A new NanoString nCounter® Mouse AD Panel was designed to correlate key human disease processes and pathways with mRNA expression from mouse brains. Analysis of two mouse models based on LOAD genetics, carrying APOE4 and TREM2.R47H alleles, demonstrated overlaps with distinct human AD modules that, in turn, are functionally enriched in key disease-associated pathways. Comprehensive comparison with full transcriptome data from same-sample RNA-seq shows strong correlation between gene expression changes independent of experimental platform. Taken together, we show that the nCounter Mouse AD Panel offers a rapid, cost-effective and highly reproducible approach to assess disease relevance of potential LOAD mouse models.

    Learning Objectives: 

    1. Reproducibly screen potential LOAD mouse models to assess disease relevance
    2. Understand design of a new resource, the Mouse AD Panel, to translate human disease processes and pathways to mouse models


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    MAR 14, 2019 9:00 AM PDT

    A Gene Expression Based Screening Platform for Mouse Models of Late-Onset Alzheimer's Disease

    Presented at: Neuroscience 2019
    Sponsored by: NanoString Technologies
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Animal Models

    Neuroscience

    Animal Research

    Brain

    Cell Biology

    Disease

    Molecular Biology

    Molecular Neuroscience

    Brain Diseases

    Human Genetics

    Biomarkers

    Cell Culture

    Molecular Genetics

    Immunology

    Research

    Geography

    Europe50%

    North America43%

    Registration Source

    Website Visitors100%

    Job Title

    Scientist29%

    Medical Laboratory Technician21%

    Post Doc14%

    Student7%

    Executive7%

    Facility/Department Manager7%

    Biologist7%

    Marketing/Sales7%

    Organization

    Academic Institution43%

    Biotech Company14%

    Hospital14%

    Medical School7%

    Pharmaceutical Company7%

    Life Science Company7%

    Other7%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more